Warning letter
International Trading Pharm Lab Inc: warning letter of Apr 24, 2020
FDA warning letter 598537 · Division of Pharmaceutical Quality Operations I
Key facts
| Reference number | 598537 |
|---|---|
| Company | International Trading Pharm Lab Inc |
| Subject | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated |
| Issue date | Apr 24, 2020 |
| Posted date | May 19, 2020 |
| Issuing office | Division of Pharmaceutical Quality Operations I |
| Product type | Drugs |
| Inspection city | Paterson |
| Inspection ZIP | 07522 |
| Inspection start date | Oct 15, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: